UEMS Medical Specialty

Cardiology & Phlebology

Evidence-based formulation strategies for cardiovascular health, including endothelial integrity, microvascular haemodynamics, venous wall support, and lipid metabolism.

13

dossiers

Microvascular Hemodynamics & Endothelial Integrity

Modulation of the Endothelial Glycocalyx and Vitamin K2-Dependent MGP Carboxylation in the Prevention of Vascular Calcification

Developing bioavailable formulations of vitamin K2 (MK-7) and novel compounds to robustly enhance endothelial glycocalyx integrity and MGP carboxylation for the prevention or reversal of vascular calcification presents significant delivery and stability challenges.

Endothelial Glycocalyx Vitamin K 2 Matrix Gla Protein Vascular Calcification

Cellular Longevity & Senolytics

Immunometabolism, Active Resolution of Inflammation, and Specialized Pro-resolving Mediators (SPMs) from EPA/DHA

Current anti-inflammatory strategies often inhibit active resolution pathways, leading to chronic inflammation. Developing stable, bioavailable specialized pro-resolving mediators (SPMs) or modulators that enhance endogenous SPM biosynthesis without compromising resolution is a significant challenge.

Specialized Pro-Resolving Mediators Resolvins Protectins Lipoxins

Post-GLP-1 Metabolic Optimization

In Vivo Gene Editing via Lipid Nanoparticles: Base Editor Mechanisms and PCSK9 Targeting

Developing safe, durable, and highly targeted in vivo delivery systems for gene editing machinery (e.g., mRNA encoding base editors) to specific tissues like the liver via LNPs remains a significant challenge, requiring precise control over biodistribution and off-target effects.

Gene Editing Lipid Nanoparticles PCSK9 protein, human Hyperlipidemias

Cellular Longevity & Senolytics

Targeted Mitochondrial Medicine: Synergistic Modulation of AMPK and NAD⁺ Salvage Pathways for Cardiometabolic Health

The challenge lies in developing stable, bioavailable, and synergistically effective combination formulations of NAD⁺ precursors and AMPK modulators to precisely target cellular bioenergetic decline in age-related cardiometabolic conditions.

Nicotinamide Adenine Dinucleotide AMP-Activated Protein Kinases Sirtuin 1 Nicotinamide Mononucleotide

Post-GLP-1 Metabolic Optimization

Nutraceutical Toxicology and Herb-Drug Interactions (HDI/NDI): A Clinical Review of Six Critical Pharmacological Mechanisms

Developing safe and effective drug formulations requires comprehensive consideration of potential, often undisclosed, herb-drug interactions that can compromise efficacy or lead to life-threatening toxicities, especially with narrow therapeutic index compounds.

Drug Interactions Nutraceuticals Herb-Drug Interactions Cytochrome P-450 Enzyme System

Transmucosal Delivery & Dosage Form Engineering

Piperine-Mediated Potentiation of Direct Oral Anticoagulants: A Clinically Unrecognized Hemorrhagic Risk

Piperine, marketed as a 'bio-enhancer' in nutraceuticals, dangerously potentiates DOACs by inhibiting P-gp and CYP3A4, leading to critical hemorrhagic risk due to uncontrolled increases in drug exposure. This unrecognized interaction demands safer alternatives for enhancing polyphenol bioavailability.

Piperine Anticoagulants, Oral Cytochrome P-450 CYP3A P-Glycoprotein

Cerebral Bioenergetics & Neuro-Metabolic Rescue

Quantum Physics and Medicine: A Review of Common Aspects

Integrating quantum phenomena, essential for advanced diagnostics and computation, into stable and functional biomedical devices for precise clinical application amidst complex biological environments presents a significant CDMO hurdle.

Quantum Theory Physics Medicine Diagnostic Imaging

Microvascular Hemodynamics & Endothelial Integrity

Common Aspects of Quantum Physics and Phlebology: A Literature Review

Developing precise, wavelength-optimized laser ablation and advanced imaging modalities for phlebology requires deep understanding of photon-tissue interaction and complex quantum phenomena, posing significant engineering and material science hurdles for consistent clinical outcomes.

Quantum Physics Phlebology Lasers Venous Insufficiency

Cellular Longevity & Senolytics

Cellular Senescence, SASP, and Senolytic Targeting of Age-Related Pathologies

Delivering senolytics effectively to specific senescent cell populations and overcoming their multi-pathway pro-survival redundancy (SCAPs) without off-target effects remains a significant challenge for therapeutic development.

Cellular Senescence Senescence-Associated Secretory Phenotype Senolytics Aging

Post-GLP-1 Metabolic Optimization

Triple Agonists and Next-Generation Oral GLP-1s: Advancements in Metabolic Disorder Therapeutics

Formulating complex multi-receptor agonists and high-potency oral GLP-1 peptides requires advanced delivery systems to ensure bioavailability, stability, and patient adherence while mitigating gastrointestinal side effects.

Glucagon-Like Peptide-1 Receptor Agonists Glucose-Dependent Insulinotropic Polypeptide Glucagon Receptor Obesity

Microvascular Hemodynamics & Endothelial Integrity

Xenotransplantation Progresses to Formal Clinical Trials: A 2026 Update on Pig-to-Human Organ Transplants

Developing xenotransplant grafts that overcome immediate immune rejection and ensure long-term physiological compatibility requires sophisticated genetic engineering and precise immunomodulatory strategies.

Blood Vessels

Precision Microbiome & Gut-Brain Axis

Enteric Delivery of Butyrate: Overcoming Gastrointestinal Barriers for Vagal Activation

Free butyrate salts dissolve prematurely in the upper gastrointestinal tract, limiting their availability for distal gut signaling. Additionally, their pungent odor and taste present significant challenges for patient adherence in chronic applications.

Aging Serotonin Gastrointestinal Microbiome Fatty Acids, Volatile

Cellular Longevity & Senolytics

Synergistic Modulation of Cellular Senescence Biomarkers by Target-Specific Nutraceutical Matrices

Developing a nutraceutical matrix that precisely modulates senescence-related biomarkers requires integrating senolytic activity, SASP suppression, and mitochondrial restoration within a single formulation while ensuring in vitro reproducibility and scalability.

Senotherapeutics Cellular Senescence NAD Inflammation

Custom Formulation Available

Need a Dossier Built Around Your Molecule?

Our R&D team will conduct a Paid Discovery Audit and build a proprietary clinical dossier for your specific active ingredient or therapeutic target. Full IP transfer included.